News
NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- PRISM MarketView today published a Q&A feature with Arun Swaminathan, Chief ...
Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on revolutionizing the ...
Clene (NASDAQ: CLNN), together with its wholly owned subsidiary, Clene Nanomedicine Inc., is advancing its lead candidate CNM-Au8®, a unique and needed oral treatment for amyotrophic lateral sclerosis ...
Front Page Detectives on MSN18h
Ancient virus in human genes could be facilitating conditions in brain triggering ALS, researchers claim
Researchers are analyzing patients with ALS and dementia to figure out jumping genes are causing them to become afflicted with ALS.
Positive data from this clinical study could lead to a registration trial of the compound for the treatment of ALS/MND. MONTREAL, QUEBEC, CANADA, September 2, 2025 /EINPresswire.com/ -- Raya ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback